TARO-FAMPRIDINE TABLET (EXTENDED-RELEASE) Canada - English - Health Canada

taro-fampridine tablet (extended-release)

taro pharmaceuticals inc - fampridine - tablet (extended-release) - 10mg - fampridine 10mg - other miscellaneous therapeutic agents

DOVATO Israel - English - Ministry of Health

dovato

glaxo smith kline (israel) ltd - dolutegravir as sodium; lamivudine - film coated tablets - lamivudine 300 mg; dolutegravir as sodium 50 mg - lamivudine and dolutegravir - dovato is indicated for the treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults and adolescents above 12 years of age weighing at least 40 kg, with no known or suspected resistance to the integrase inhibitor class, or lamivudine and viral load ≤500,000 c/ml.

Tivicay 5mg Dispersible Tablets Tanzania - English - Tanzania Medicinces & Medical Devices Authority

tivicay 5mg dispersible tablets

glaxosmithkline pharmaceutical kenya limited, kenya - dolutegravir sodium - dispersible tablets - 5

TIVICAY 5  MG DISPERSIBLE TABLETS Israel - English - Ministry of Health

tivicay 5 mg dispersible tablets

glaxo smith kline (israel) ltd - dolutegravir as sodium - dispersible tablets - dolutegravir as sodium 5 mg - dolutegravir - tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 4 weeks of age or older and weighing at least 3 kg.